These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 16116478)
21. [Effect of transcriptional factor snail on epithelial-mesenchymal transition and tumor metastasis]. Zhang AL; Wang QS; Zhong YH; Chen G; Xi L; Xie CH; Zhou YF; Ma D Ai Zheng; 2005 Nov; 24(11):1301-5. PubMed ID: 16552952 [TBL] [Abstract][Full Text] [Related]
22. β-elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells. Zhang X; Zhang Y; Li Y Oncol Rep; 2013 Aug; 30(2):745-50. PubMed ID: 23732279 [TBL] [Abstract][Full Text] [Related]
23. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349 [TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines. Tsutsumida A; Hamada J; Tada M; Aoyama T; Furuuchi K; Kawai Y; Yamamoto Y; Sugihara T; Moriuchi T Int J Oncol; 2004 Nov; 25(5):1415-21. PubMed ID: 15492833 [TBL] [Abstract][Full Text] [Related]
25. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Batlle E; Sancho E; Francí C; Domínguez D; Monfar M; Baulida J; García De Herreros A Nat Cell Biol; 2000 Feb; 2(2):84-9. PubMed ID: 10655587 [TBL] [Abstract][Full Text] [Related]
26. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition. Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758 [TBL] [Abstract][Full Text] [Related]
27. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928 [TBL] [Abstract][Full Text] [Related]
28. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma]. Li Z; Lin SX; Liang YJ Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799 [TBL] [Abstract][Full Text] [Related]
29. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7. Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947 [TBL] [Abstract][Full Text] [Related]
30. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
32. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element. Rodrigo I; Cato AC; Cano A Exp Cell Res; 1999 May; 248(2):358-71. PubMed ID: 10222128 [TBL] [Abstract][Full Text] [Related]
33. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959 [TBL] [Abstract][Full Text] [Related]
34. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180 [TBL] [Abstract][Full Text] [Related]
35. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation. Albergaria A; Ribeiro AS; Pinho S; Milanezi F; Carneiro V; Sousa B; Sousa S; Oliveira C; Machado JC; Seruca R; Paredes J; Schmitt F Hum Mol Genet; 2010 Jul; 19(13):2554-66. PubMed ID: 20385540 [TBL] [Abstract][Full Text] [Related]
36. Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Andersen H; Mejlvang J; Mahmood S; Gromova I; Gromov P; Lukanidin E; Kriajevska M; Mellon JK; Tulchinsky E Mol Cell Biol; 2005 Oct; 25(20):9138-50. PubMed ID: 16199889 [TBL] [Abstract][Full Text] [Related]
37. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells. Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012 [TBL] [Abstract][Full Text] [Related]
38. Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression. Wang CA; Drasin D; Pham C; Jedlicka P; Zaberezhnyy V; Guney M; Li H; Nemenoff R; Costello JC; Tan AC; Ford HL Cancer Res; 2014 Dec; 74(24):7357-70. PubMed ID: 25348955 [TBL] [Abstract][Full Text] [Related]
39. E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications. Takeno S; Noguchi T; Fumoto S; Kimura Y; Shibata T; Kawahara K Am J Clin Pathol; 2004 Jul; 122(1):78-84. PubMed ID: 15272533 [TBL] [Abstract][Full Text] [Related]
40. Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis. Faraldo ML; Rodrigo I; Behrens J; Birchmeier W; Cano A Mol Carcinog; 1997 Sep; 20(1):33-47. PubMed ID: 9328434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]